Evidence map›Paper›PMID 16714535›Full record

ArticleInfection and immunity2006

Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Liise-Anne Pirofski

Abstract readComment
In one paragraph

Article in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. The capsule of the fungal pathogen Cryptococcus neoformans.Advances in applied microbiology · 2009
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Liise-Anne PirofskiDivision of Infectious Diseases, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. Pirofski@aecom.yu.edu

Funding

VARIABLE GENE USE AND PNEUMOCOCCAL IMMUNITY IN AIDSR01AI045459 · NIAID · YESHIVA UNIVERSITY · PI PIROFSKI, LIISE-ANNE · 2000 to 2010
$3.9M
Human Antibodies to Crytococcus NeoformansR01AI035370 · NIAID · YESHIVA UNIVERSITY · PI PIROFSKI, LIISE-ANNE · 1994 to 2009
$3.3M
VARIABLE GENE DEFECTS AND PNEUMOCOCCAL SUSCEPTIBILITYR01AI044374 · NIAID · YESHIVA UNIVERSITY · PI PIROFSKI, LIISE-ANNE · 2001 to 2010
$2.7M
NIAID NIH HHS AI44374NIAID NIH HHS AI45459NIAID NIH HHS R01 AI035370NIAID NIH HHS R01 AI044374NIAID NIH HHS R01 AI045459NIAID NIH HHS R01 AI35370
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Complement ActivationAnimalsBacterial CapsulesComplement C3Cryptococcus neoformansHIV InfectionsHumansOpsonin ProteinsPolysaccharidesComplement C3glucuronoxylomannanOpsonin ProteinsPolysaccharides

Identifiers

PMID16714535
PMCPMC1479240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.